Verrica Pharmaceuticals Inc. (VRCA)

Verrica Pharmaceuticals Statistics

Total Valuation

VRCA has a market cap or net worth of $84.91 million. The enterprise value is $97.16 million.

Market Cap	84.91M
Enterprise Value	97.16M

Important Dates

The next estimated earnings date is Thursday, November 7, 2024, before market open.

Earnings Date	Nov 7, 2024
Ex-Dividend Date	n/a

Share Statistics

VRCA has 42.67 million shares outstanding. The number of shares has increased by 8.69% in one year.

Shares Outstanding	42.67M
Shares Change (YoY)	+8.69%
Shares Change (QoQ)	+0.04%
Owned by Insiders (%)	37.65%
Owned by Institutions (%)	17.83%
Float	15.50M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	6.47
Forward PS	5.28
PB Ratio	n/a
P/FCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	6.99
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.36

Current Ratio	2.36
Quick Ratio	2.10
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-9.06

Financial Efficiency

Return on equity (ROE) is -412.98% and return on invested capital (ROIC) is -109.04%.

Return on Equity (ROE)	-412.98%
Return on Assets (ROA)	-85.72%
Return on Capital (ROIC)	-109.04%
Revenue Per Employee	$139,080
Profits Per Employee	-$869,330
Employee Count	100
Asset Turnover	0.24
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -54.88% in the last 52 weeks. The beta is 1.47, so VRCA's price volatility has been higher than the market average.

Beta (5Y)	1.47
52-Week Price Change	-54.88%
50-Day Moving Average	5.03
200-Day Moving Average	6.03
Relative Strength Index (RSI)	21.10
Average Volume (20 Days)	1,290,949

Short Selling Information

The latest short interest is 2.98 million, so 6.99% of the outstanding shares have been sold short.

Short Interest	2.98M
Short Previous Month	4.19M
Short % of Shares Out	6.99%
Short % of Float	19.23%
Short Ratio (days to cover)	6.46

Income Statement

In the last 12 months, VRCA had revenue of $13.91 million and -$86.93 million in losses. Loss per share was -$1.88.

Revenue	13.91M
Gross Profit	-8.41M
Operating Income	-78.32M
Pretax Income	-80.74M
Net Income	-86.93M
EBITDA	-77.52M
EBIT	-78.32M
Loss Per Share	-$1.88

Balance Sheet

The company has $31.93 million in cash and $46.31 million in debt, giving a net cash position of -$14.38 million or -$0.34 per share.

Cash & Cash Equivalents	31.93M
Total Debt	46.31M
Net Cash	-14.38M
Net Cash Per Share	-$0.34
Equity (Book Value)	-13.30M
Book Value Per Share	-0.31
Working Capital	27.27M

Cash Flow

In the last 12 months, operating cash flow was -$65.62 million and capital expenditures -$303,000, giving a free cash flow of -$65.93 million.

Operating Cash Flow	-65.62M
Capital Expenditures	-303,000
Free Cash Flow	-65.93M
FCF Per Share	-$1.55

Margins

Gross Margin	-60.48%
Operating Margin	-563.14%
Pretax Margin	-625.06%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-609.05%

Dividends & Yields

VRCA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-8.69%
Shareholder Yield	-8.69%
Earnings Yield	-105.02%
FCF Yield	-79.64%

Analyst Forecast

The average price target for VRCA is $12.25, which is 515.58% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$12.25
Price Target Difference	515.58%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	132.41%
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

VRCA has an Altman Z-Score of -9.12 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-9.12
Piotroski F-Score	3